SCHEMBL31689336

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	BACE1	P56817	2/20	0.45

▸	GLP1R	P43220	1/20	0.44

▸	GCGR	P47871	1/20	0.44

▸	GIPR	P48546	1/20	0.44

▸	RXFP1	Q9HBX9	2/20	0.44

▸	VIPR2	P41587	3/20	0.42

▸	VIPR1	P32241	3/20	0.42

▸	TFPI	P10646	1/20	0.41

▸	FNTA	P49354	4/20	0.41

▸	FNTB	P49356	4/20	0.41

▸	PTH1R	Q03431	1/20	0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30262014	0.96	RXFP1 (0.47)	BACE1GLP1RGCGRGIPRRXFP1
SCHEMBL31257159	0.94	TFPI (0.44)	BACE1RXFP1VIPR2VIPR1TFPI
SCHEMBL29561758	0.89	VIPR2 (0.50)	BACE1GLP1RGCGRGIPRRXFP1
SCHEMBL30844296	0.89	TFPI (0.44)	RXFP1VIPR2VIPR1TFPI
SCHEMBL30173898	0.89	FOLH1 (0.44)	FNTAFNTB
SCHEMBL30173824	0.89	FOLH1 (0.44)	FNTAFNTB
SCHEMBL30140914	0.88	BACE1 (0.48)	BACE1RXFP1TFPI
SCHEMBL31157682	0.88	VIPR2 (0.43)	BACE1GLP1RGCGRGIPRRXFP1
SCHEMBL30082474	0.87	RXFP1 (0.42)	BACE1RXFP1VIPR2VIPR1PTH1R
SCHEMBL30804675	0.87	BACE1 (0.49)	BACE1RXFP1VIPR2VIPR1TFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025195444-A1	NEW USE OF PEPTIDES DERIVED FROM VASOACTIVE INTESTINAL PEPTIDE	Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN)	2025-09-25	—	—	WO	disclosed